{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:54:13Z","timestamp":1793091253058,"version":"4.5.0"},"reference-count":113,"publisher":"Informa UK Limited","issue":"7","funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.1080\/14760584.2018.1495565","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T19:12:07Z","timestamp":1532113927000},"page":"619-634","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":110,"title":["Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention"],"prefix":"10.1080","volume":"17","author":[{"given":"Nicolas","family":"Lecrenier","sequence":"first","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Beukelaers","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romulo","family":"Colindres","sequence":"additional","affiliation":[{"name":"GSK, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Curran","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"De Kesel","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"De Saegher","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud M","family":"Didierlaurent","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard Y","family":"Ledent","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann F","family":"Mols","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Mrkvan","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Normand-Bayle","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Oostvogels","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Tavares","family":"Da Silva","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ventzislav","family":"Vassilev","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Vinals","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-0541","authenticated-orcid":false,"given":"Alain","family":"Brecx","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1086\/522123"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S106340"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1177\/2051013615599151"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1086\/528696"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1086\/605611"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1086\/653605"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1002\/path.2104"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.051"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a3516e"},{"key":"CIT0010","author":"Cohen JI, Straus SE, Arvin AM","year":"2007","journal-title":"Knipe DM, Howley PM, editors"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/art.39670"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0815"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.06.016"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2014.901554"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1514-y"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0420-9"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10364"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.4065\/82.11.1341"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84a.16020"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit405"},{"key":"CIT0021","first-page":"CD006866","author":"Chen N","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13957"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.01.359"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1086\/379048"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis638"},{"key":"CIT0027","unstructured":"ZOSTAVAX\u00ae (Zoster Vaccine Live). Product information. [cited 2017 Apr 19]. Available from https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM132831.pdf."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"CIT0030","unstructured":"Varivax. Prescribing information. [cited 2017 June 01]. Available from https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM142813.pdf."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir970"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu918"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw854"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001420"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw047"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx245"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.04.015"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/IAI.38.2.554-557.1982","volume":"38","author":"Kamiya H","year":"1982","journal-title":"Infect Immun"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.4049\/jimmunol.136.11.4243","volume":"136","author":"Tilden AB","year":"1986","journal-title":"J Immunol"},{"key":"CIT0040","first-page":"182","volume":"65","author":"Ito M","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.07.020"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.0064"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(95)01270-2"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03633.x"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00073-V"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00533-06"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912373107"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1128\/JVI.71.11.8279-8288.1997","volume":"71","author":"Mallory S","year":"1997","journal-title":"J Virol"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00475-3"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.088"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1154247"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1086\/600120"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1225635"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis497"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.4.7.1129"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.29"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1038\/srep39475"},{"key":"CIT0058","first-page":"663","volume":"7","author":"Welsby I","year":"2016","journal-title":"Front Immunol"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400948"},{"key":"CIT0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-017-0027-3","volume":"2","author":"Coccia M","year":"2017","journal-title":"NPJ Vaccines"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2016.1213632"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit365"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.019"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.073"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24269"},{"key":"CIT0066","volume-title":"U.S. Department of Health and Human Services","author":"Food and Drug Administration. Guidance for industry for the evaluation of combination vaccines for preventable diseases: production, testing and clinical studies","year":"1997"},{"key":"CIT0067","volume-title":"Committee for medicinal products for human use. Guideline on clinical evaluation of new vaccines","author":"European Medicines Agency"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1043501"},{"key":"CIT0069","unstructured":"Press release. GSK announces first approval of Shingrix in Canada. Media release. 13 October 2017.[cited 2017 Oct 20]. Available from https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-announces-first-approval-of-shingrix-in-canada\/"},{"key":"CIT0070","unstructured":"Press release. Shingrix approved in the US for prevention of shingles in adults aged 50 and over. 23 October 2017. [cited 2017 Oct 26]. Available from https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/shingrix-approved-in-the-us-for-prevention-of-shingles-in-adults-aged-50-and-over\/"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-573048"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu606"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3329"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2017.03.015"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix482"},{"key":"CIT0076","first-page":"4278","volume-title":"a randomized trial. Vaccine","volume":"36","author":"Marechal\u00a0C,\u00a0Lal\u00a0H,\u00a0Poder\u00a0A","year":"2018"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.1039"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.039"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.042"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1232787"},{"key":"CIT0081","doi-asserted-by":"crossref","unstructured":"Poder A, Geeraerts B, Lal H, et al. Immunogenicity and safety of 2 doses of an investigational herpes zoster subunit vaccine administered 2, 6 or 12\u00a0months apart in adults 50\u00a0years and older: results of a phase III, randomized, open-label, multicenter trial. Open Forum Infect Dis. 2016;3(Suppl 1):753.","DOI":"10.1093\/ofid\/ofw172.616"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2012.12.013"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.06.001"},{"key":"CIT0084","doi-asserted-by":"crossref","unstructured":"McElhaney\u00a0JE,\u00a0Lal\u00a0H,\u00a0Cunningham\u00a0A, et\u00a0al. Efficacy, immunogenicity and safety of an investigational subunit adjuvanted herpes zoster vaccine in adults aged 60\u00a0years and older: results from the ZOE-50 and ZOE-70 efficacy studies. Open Forum Infect Dis. 2016;3(Suppl 1):127.","DOI":"10.1093\/ofid\/ofw194.40"},{"key":"CIT0085","unstructured":"de la Serna J, Campora L, Chandrasekar P, et al. Efficacy and safety of an adjuvanted herpes zoster subunit vaccine in autologous hematopoietic stem cell transplant recipients 18 years of age or older: first results of the phase 3 randomized, placebo-controlled ZOE-HSCT clinical trial. Abstract LBA2. BMT Tadem meetings; 2018 February 21-25; Utah, US. Available from: https:\/\/bmt.confex.com\/tandem\/2018\/meetingapp.cgi\/Paper\/11724."},{"key":"CIT0086","unstructured":"Sullivan K, Abhyankar S, Campora L, et al. Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine in adult autologous hematopoietic stem cell transplant recipients: phase 3, randomized, placebo-controlled, ZOE-HSCT clinical trial. Abstract OS9-2. 44th Annual meeting of the European Society for Blood and Marrow Transplantation; March 18-21, 2018; Lisbon, Portugal."},{"key":"CIT0087","doi-asserted-by":"crossref","unstructured":"Schwarz T, Aggarwal N, Moeckesch B, et al. Randomized, phase III clinical trial to assess the immunogenicity and safety of an investigational subunit adjuvanted herpes zoster vaccine coadministered with a seasonal quadrivalent inactivated influenza vaccine in adults aged 50\u00a0years and older. Open Forum Infect Dis. 2016;3(Suppl 1):751.","DOI":"10.1093\/ofid\/ofw172.614"},{"key":"CIT0088","unstructured":"Shingrix Prescribing Information. [cited 2017 Nov 08]. Available from https:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm581491.htm"},{"key":"CIT0089","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Fauqued\u00a0M,\u00a0Campora\u00a0L,\u00a0Delannois\u00a0F, et\u00a0al. Results of a safety pooled analysis of an adjuvanted herpes zoster subunit vaccine in more than 14,500 participants aged 50\u00a0years or older. Open Forum Infect Dis. 2017;4(Suppl 1):S416.","DOI":"10.1093\/ofid\/ofx163.1042"},{"key":"CIT0090","doi-asserted-by":"crossref","unstructured":"Vink\u00a0P.\u00a0For the Zoster-028 study group. Immunogenicity and safety of a candidate subunit adjuvanted herpes zoster vaccine in adults with solid tumors vaccinated before or during immunosuppressive chemotherapy treatment: a phase II\/III, randomized clinical trial. Open Forum Infect Dis. 2017;4(Suppl 1):S417-S418.","DOI":"10.1093\/ofid\/ofx163.1045"},{"key":"CIT0091","doi-asserted-by":"crossref","unstructured":"Oostvogels\u00a0L.\u00a0For the Zoster-039 study group. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults with hematologic malignancies: a phase III, randomized clinical trial. Open Forum Infect Dis. 2017;4(Suppl 1):S415.","DOI":"10.1093\/ofid\/ofx163.1040"},{"key":"CIT0092","doi-asserted-by":"crossref","unstructured":"Vink\u00a0P.\u00a0For the Zoster-041 study group.\u00a0Immunogenicity and safety of a candidate subunit adjuvanted herpes zoster vaccine (HZ\/su) in adults post renal transplant: a phase III randomized clinical trial. Open Forum Infect Dis. 2017;4(Suppl 1):S417.","DOI":"10.1093\/ofid\/ofx163.1044"},{"key":"CIT0093","unstructured":"Centers for Disease Control and Prevention. Shingles (Herpes Zoster). [cited 2017 Jun 05]. Available from https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview.html#complications"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-230"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis575"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1753-y"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-173"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.045"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1007\/s10935-015-0394-3"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01231.x"},{"key":"CIT0102","unstructured":"Varghese L, Nissen MD, Olivier A, et al. Public health perspective of phase III results of an investigational herpes zoster vaccine. Communicable Disease Control Conference 2015 June 1\u20132. Brisbane Australia. [cited 2017 May 06]. Available from https:\/\/www.phaa.net.au\/eventsinfo\/communicable-disease-control-conference-2."},{"key":"CIT0103","unstructured":"Van Oorschot D, Anastassopoulou A, Schlegel K, et al. The Public Health Impact Of A New Herpes Zoster Vaccine On The German Population. [cited 2017 May 05]. Available from: https:\/\/www.ispor.org\/research_pdfs\/54\/pdffiles\/PIH6.pdf"},{"key":"CIT0104","volume-title":"Canadian Immunization Conference - 12th","volume":"2016","author":"Van Oorschot D"},{"key":"CIT0105","unstructured":"Van Oorschot D, Hunjan E, Varghese L, et al. The Public Health Perspective Of An Investigational Herpes Zoster Vaccine In The United Kingdom (UK). [cited 2017 May 05]. Available from https:\/\/www.ispor.org\/research_pdfs\/54\/pdffiles\/PIH5.pdf"},{"key":"CIT0106","doi-asserted-by":"crossref","unstructured":"Varghese L, Curran D, Yan S, et al. Estimating the potential public health impact of introducing the RZV vaccine in the US population aged \u226550\u00a0years. ID Week 2015. 2015 Oct 10.[cited 2017 May 02]. Available from: https:\/\/idsa.confex.com\/idsa\/2015\/webprogram\/Paper52887.html.","DOI":"10.1093\/ofid\/ofv133.1477"},{"key":"CIT0107","first-page":"1","volume":"14","author":"Curran D","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.016"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1026"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.079"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.05.007"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12809"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit344"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2018.1495565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T21:51:18Z","timestamp":1693777878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2018.1495565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,3]]}},"alternative-id":["10.1080\/14760584.2018.1495565"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2018.1495565","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}